))
The New Faces of Houston Biotech _ e.052
Manage episode 414333470 series 3006114
Conteúdo fornecido por John Flavin. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por John Flavin ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
In this episode of "Lab Rats to Unicorns," recorded at TMC's Helix Park in Houston during a Portal Pours event, we're joined by a distinguished panel led by featured host Ritu Shah, a seasoned expert in the biopharma industry and Managing Director at Portal Innovations. The conversation features:
- Sarah Hein, the visionary founding CEO of March Biosciences, a trailblazer in clinical-stage cell-therapy, with a rich background in cancer therapeutics and antibody therapeutics platform technologies.
- Rahul Aras, a dedicated executive with a robust 15+ years in the pharma/biotech sector, currently leading the charge in early-stage technology advancement and business development, recognized for his role at Iterion Therapeutics.
- Michael Torres, an entrepreneur with a fervent mission to turn science into medicine, leveraging his experience in biotech company formation and equity research to make significant strides at Crossbridge Biotech.
Together, they delve into the dynamics of Houston's biotech ecosystem, sharing their unique perspectives on innovation, the challenges of startup culture, and the path forward in transforming patient care.
61 episódios
Compartilhar
